• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine.

作者信息

Lacosta S, Roberts D C

机构信息

Department of Psychology, Carleton University, Ottawa, Canada.

出版信息

Pharmacol Biochem Behav. 1993 Jan;44(1):161-5. doi: 10.1016/0091-3057(93)90295-5.

DOI:10.1016/0091-3057(93)90295-5
PMID:8430119
Abstract

The effects of three serotonin [5-hydroxytryptamine (5-HT)] receptor antagonists on cocaine self-administration behavior were investigated. Specifically, the effects of MDL 72222 (a specific 5-HT3 receptor antagonist), ketanserin (a specific 5HT2 receptor antagonist), and methysergide (an aselective 5-HT1/5-HT2 receptor antagonist) on the breaking points reached by rats on a progressive ratio schedule for cocaine reinforcement were examined. Pretreatments with MDL 72222 (7.5-1,920 micrograms/kg, SC), ketanserin (0.4-6.4 mg/kg, IP), and methysergide (2.5-20 mg/kg, IP) failed to alter breaking points from baseline values. Although tested at twice the highest doses previously reported to have significant behavioral effects, the three 5-HT receptor antagonists were without effect. These data suggest that relatively specific blockade of 5-HT receptor subtypes does not influence the reinforcing effects of cocaine.

摘要

相似文献

1
MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine.
Pharmacol Biochem Behav. 1993 Jan;44(1):161-5. doi: 10.1016/0091-3057(93)90295-5.
2
Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.有证据表明,脊髓5-羟色胺1、5-羟色胺2和5-羟色胺3受体亚型可调节大鼠对结直肠扩张性伤害刺激的反应。
Brain Res. 1991 Jan 4;538(1):64-75. doi: 10.1016/0006-8993(91)90377-8.
3
Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
J Pharmacol Exp Ther. 1988 Feb;244(2):650-8.
4
Evidence for depressant 5-HT1-like receptors on rat brainstem neurones.大鼠脑干神经元上存在抑制性5-羟色胺1样受体的证据。
Br J Pharmacol. 1988 Jun;94(2):492-9. doi: 10.1111/j.1476-5381.1988.tb11552.x.
5
Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.迷走神经传入介导的静脉注射血清素对大鼠伤害性反射的抑制作用。II. 5-羟色胺受体亚型的作用。
Brain Res. 1992 Jul 10;585(1-2):71-86. doi: 10.1016/0006-8993(92)91192-h.
6
L-tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat.
Pharmacol Biochem Behav. 1993 Mar;44(3):651-5. doi: 10.1016/0091-3057(93)90181-r.
7
Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.喹哌嗪和间氯苯双胍(m-CPBG)对时间辨别能力的影响:5-HT2A受体而非5-HT3受体参与间隔计时行为的证据。
Psychopharmacology (Berl). 2005 Sep;181(2):289-98. doi: 10.1007/s00213-005-2233-3. Epub 2005 Oct 14.
8
GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.GR38032F,一种5-羟色胺5-HT3拮抗剂,不会改变大鼠的可卡因自我给药行为。
Pharmacol Biochem Behav. 1991 May;39(1):133-6. doi: 10.1016/0091-3057(91)90410-4.
9
Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks.三种5-羟色胺受体拮抗剂对大鼠注意力和工作记忆任务表现的不同影响。
Eur Neuropsychopharmacol. 1997 May;7(2):99-108. doi: 10.1016/s0924-977x(96)00389-6.
10
Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.血清素参与对大鼠可卡因诱导的运动活动的调节。
Pharmacol Biochem Behav. 1998 Mar;59(3):595-611. doi: 10.1016/s0091-3057(97)00473-5.

引用本文的文献

1
Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.联合应用匹莫范色林和lorcaserin 抑制可卡因似复发行为。
Neuropharmacology. 2020 May 15;168:108009. doi: 10.1016/j.neuropharm.2020.108009. Epub 2020 Feb 14.
2
The 5-HT Receptor (5-HTR) Regulates Impulsive Action and Cocaine Cue Reactivity in Male Sprague-Dawley Rats.5-羟色胺受体(5-HTR)调节雄性 Sprague-Dawley 大鼠的冲动行为和可卡因线索反应性。
J Pharmacol Exp Ther. 2019 Jan;368(1):41-49. doi: 10.1124/jpet.118.251199. Epub 2018 Oct 29.
3
The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders.
氯卡色林治疗物质使用障碍的行为药理学和治疗潜力。
Neuropharmacology. 2018 Nov;142:63-71. doi: 10.1016/j.neuropharm.2017.12.023. Epub 2017 Dec 12.
4
Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.冲动性与成瘾中的趋同药理机制:来自啮齿动物模型的见解
Br J Pharmacol. 2014 Oct;171(20):4729-66. doi: 10.1111/bph.12787. Epub 2014 Sep 5.
5
The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.5-羟色胺3受体在药物滥用中的作用以及作为药物治疗靶点的作用。
CNS Neurol Disord Drug Targets. 2008 Nov;7(5):454-67. doi: 10.2174/187152708786927886.
6
Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates.大鼠伏隔核6-羟基多巴胺损伤对可卡因自我给药及微透析液中多巴胺水平影响的时间依赖性恢复。
Psychopharmacology (Berl). 2004 Feb;171(4):413-20. doi: 10.1007/s00213-003-1596-6. Epub 2003 Sep 23.
7
Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice.可卡因对血清素5-羟色胺2C受体突变小鼠的运动、强化及神经化学作用增强。
J Neurosci. 2002 Nov 15;22(22):10039-45. doi: 10.1523/JNEUROSCI.22-22-10039.2002.
8
Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.阻断腹侧被盖区的D1多巴胺受体可降低可卡因奖赏效应:树突释放多巴胺的潜在作用
J Neurosci. 2001 Aug 1;21(15):5841-6. doi: 10.1523/JNEUROSCI.21-15-05841.2001.
9
The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.5-羟色胺5-HT3受体拮抗剂的非止吐用途。临床药理学与治疗应用。
Drugs. 1997 Jan;53(1):20-39. doi: 10.2165/00003495-199753010-00003.
10
Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.右旋芬氟拉明和麦角新碱对条件性奖赏反应的影响以及伏隔核右旋苯丙胺的反应增强作用。
Psychopharmacology (Berl). 1995 Mar;118(2):155-63. doi: 10.1007/BF02245834.